CHAARTED and STAMPEDE Impacting Treatment for Metastatic Hormone Sensitive Prostate Cancer Patients - 101341

Spotlight
Video

CHAARTED and STAMPEDE Impacting Treatment for Metastatic Hormone Sensitive Prostate Cancer Patients

obr has 439 videos Subscribe Here

Loading........
Description: Ana Aparicio, MD of MD Anderson Cancer Center discusses how the CHARTED and STAMPEDE trials impacted her treatment for patients with metastatic hormone sensitive prostate cancer at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Shared By : obr
Posted on : 02/22/17
Added : 1 year ago
Category : Prostate Cancer